NAC species showed more resistance to
fluconazole, voriconazole, caspofungin, micafungin, and amphotericin B as compared to C.
Generic
fluconazole products (50- and 200-mg tablets; 10and 40-mg/mL oral suspensions) served as refer ences.
According to the antifungal resistance data of this study, cross-resistance between
fluconazole and voriconazole was found among 18(8.
krusei show primary resistance to
fluconazole [11].
7-10) Doses of
fluconazole generally [greater than or equal to] 200 mg/d are needed to produce clinical interactions with CYP3A4 substrates.
5 Other drugs like
Fluconazole and Miconazole in specified concentrations6 and hydrocortisone sodium succinate (HSS) are also mentioned in literature as Drug delivery devices for treatment of recurrent ulcers.
4 shows out of 53 isolates, Candida albicans which showed sensitivity to Voriconazole were 92%, Flucytosine were 92% Amphotericin B were 89%,
Fluconazole were 81%, Micafungin were 78%, Caspofungin were 75%.
Oral
fluconazole is used to treat yeast infections of the vaginal area, mouth, and esophagus.
Fluconazole is not FDA approved for onychomycosis, but it is used quite commonly to treat both fingernail and toenail fungal infections.
Conclusion: Efficacy of Intramuscular meglumine antimoniate is better than oral
fluconazole in treatment of cutaneous leishmaniasis.
Fluconazole is antifungal drug effective against most of the Candida species, although different degrees of susceptibility among species have been described including that observed in Malaysia.
Key words: Candidiasis, non albicans Candida, chromagar, amphotericin B,
fluconazole, caspofungin.
